Immunovant, Inc. IMVT
- imeroprubart — Graves' Disease Phase 2
- imeroprubart — Rheumatoid Arthritis Phase 2
- imeroprubart — Myasthenia Gravis Phase 3
- imeroprubart — Chronic Inflammatory Demyelinating Polyneuropathy Phase 2
Companies with an active program directed at FcRn.